164 related articles for article (PubMed ID: 16149600)
1. [CA19-9].
Odagiri E
Nihon Rinsho; 2005 Aug; 63 Suppl 8():642-4. PubMed ID: 16149600
[No Abstract] [Full Text] [Related]
2. [2-->6 Sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
[No Abstract] [Full Text] [Related]
3. [CA50].
Kawabe T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():645-6. PubMed ID: 16149601
[No Abstract] [Full Text] [Related]
4. [Carcinoembryonic antigen (CEA)].
Kinugasa T; Kuroki M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
[No Abstract] [Full Text] [Related]
5. [NCC-ST-439].
Sugano K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
[No Abstract] [Full Text] [Related]
6. [Immunosuppressive acid protein (IAP)].
Ikeda H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():711-2. PubMed ID: 16149619
[No Abstract] [Full Text] [Related]
7. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
[No Abstract] [Full Text] [Related]
8. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Koike T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
[No Abstract] [Full Text] [Related]
9. [Tissue polypeptide antigen (TPA)].
Sugiyama Y; Kawaguchi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():705-7. PubMed ID: 16149617
[No Abstract] [Full Text] [Related]
10. [Basic fetoprotein (BFP)].
Ishii M; Seino Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():629-31. PubMed ID: 16149596
[No Abstract] [Full Text] [Related]
11. [CA15-3].
Inaji H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():651-3. PubMed ID: 16149603
[No Abstract] [Full Text] [Related]
12. [CA19-9].
Odagiri E
Nihon Rinsho; 1999 Dec; 57 Suppl():459-61. PubMed ID: 10778164
[No Abstract] [Full Text] [Related]
13. [The diagnostic value of determining the level of the carbohydrate antigen 19-9 in pancreatic cancer].
Moroz GS; Les'kiv IM
Klin Khir (1962); 1993; (2):34-5. PubMed ID: 10912065
[TBL] [Abstract][Full Text] [Related]
14. CA19-9: the Italian experience.
Gullo L
Pancreas; 1994 Nov; 9(6):717-9. PubMed ID: 7846014
[TBL] [Abstract][Full Text] [Related]
15. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
Hasholzner U; Stieber P; Reiter W; Zimmermann A; Hofmann K; Schalhorn A
Anticancer Res; 1999; 19(4A):2477-80. PubMed ID: 10470177
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of Span-1 antigen assay as a tumor marker].
Satake K; Chung YS; Umeyama K
Nihon Rinsho; 1990 Feb; 48 Suppl():1053-6. PubMed ID: 2355504
[No Abstract] [Full Text] [Related]
17. [An attempt for standardization of serum CA19-9 levels, in order to dissolve the gap between three different methods].
Hayashi K; Hoshino T; Yanai M; Tsuchiya T; Kumasaka K; Kawano K
Rinsho Byori; 2004 Jun; 52(6):500-5. PubMed ID: 15283162
[TBL] [Abstract][Full Text] [Related]
18. [Lewis antigens and CA19-9].
Naka K; Shimojo N
Nihon Rinsho; 1998 Jan; 56 Suppl 3():117-20. PubMed ID: 9513400
[No Abstract] [Full Text] [Related]
19. [Neuron specific enolase].
Odagiri E
Nihon Rinsho; 2005 Aug; 63 Suppl 8():717-9. PubMed ID: 16149621
[No Abstract] [Full Text] [Related]
20. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
